University Hospitals Bristol lead and contribute to world-class medical research studies to drive the very best treatment and care. Research is essential to advance patient care, help scientists better understand diseases and discover new and improved treatments.

Research is expensive which is where Above & Beyond help. By funding innovative studies new research can benefit the patients of today and tomorrow.

  • For every £1 that we invest into research, a further £16 is attracted in new, larger grants.
  • Funds provided go towards research project costs and funding individual researchers.

Examples of research our supporters have funded:

  • Development of a new blood test in patients with Immune Thrombocytopenia (ITP) to predict responses to steroid treatment. Our corporate partner Dribuild contributed £53,000 to this study. Dr Charlotte Bradbury, ITP Research Lead pictured with the Dribuild team, staff from Above & Beyond and Meg, a patient being treated for ITP, said “The incredible funding given will be essential to help us develop new blood tests that can predict the best early treatments for patients to help avoid side effects and, most importantly, make them better quicker.”

  • Electrotherapy treatment for haemophilia patients to investigate the use of a pulsed magnetic field treatment in acute bleed management for patients with haemophilia. Patients with haemophilia are not able to form blood clots, so are at risk of long bleeds and internal bleeds. The aim is to determine whether this treatment should be routinely offered to haemophilia patients with acute bleeds.

  • Discovering new treatment for colorectal cancer with a £20,000 grant to fund a study into how 5-aminosalicyclic acid can be used to target cancer stem calls to prevent the colon cancer progressing. Funding this pump priming study will enable future clinical trials to be designed, with support from a larger funding body, which will directly lead to new treatments for patients.

You can help our hospitals continue to be at the forefront of innovative research, please donate here. Thank you.